1.Outbreak Investigation of Scarlet Fever in a Kindergarten.
Infection and Chemotherapy 2018;50(1):65-66
No abstract available.
Scarlet Fever*
2.Outbreak Investigation of Scarlet Fever in a Kindergarten.
Infection and Chemotherapy 2018;50(1):65-66
No abstract available.
Scarlet Fever*
3.A case of Henoch-Schonlein purpura associated with scarlet fever.
Hee Shang YOON ; Byung Kiu PARK ; Myung Kul YUM
Journal of the Korean Pediatric Society 1989;32(11):1581-1585
No abstract available.
Purpura, Schoenlein-Henoch*
;
Scarlet Fever*
5.Effectiveness of Varicella Vaccination Program in Preventing Laboratory-Confirmed Cases in Children in Seoul, Korea.
Young Hwa LEE ; Young June CHOE ; Sung Il CHO ; Cho Ryok KANG ; Ji Hwan BANG ; Myoung Don OH ; Jong Koo LEE
Journal of Korean Medical Science 2016;31(12):1897-1901
A universal one-dose varicella vaccination program was introduced in 2005 in Republic of Korea. However, the incidence of varicella in Korea has tripled over the last decade. We conducted a community based 1:1 matched case-control study to assess the effectiveness of one MAV strain-based vaccine and three Oka strain-based vaccines licensed for use in Korea. All cases were children in Seoul, Korea with varicella who were reported to the National Notifiable Disease Surveillance System in Seoul during 2013. The controls were age-matched children with mumps or scarlet fever but no history of varicella. We included 537 cases and 537 controls. The overall effectiveness of one dose of varicella vaccination was 13% (95% confidence interval [CI], −17.3–35.6). Of the four licensed varicella vaccines, only one was highly effective (88.9%; 95% CI, 52.1–97.4). The vaccine effectiveness for the other vaccines were 71.4% (95% CI, −37.5–94.1), −5% (95% CI, −61.9–31.9), and −100% (95% CI, −700–50.0). The overall effectiveness of vaccination was 75.8% (95% CI, 22.8–92.4) in the first year after vaccination and decreased thereafter; the effectiveness became −7.2% (95% CI, −130.9–59.2) in the fourth year after vaccination. Further studies are warranted to investigate reduced effectiveness of varicella vaccines in Korea.
Case-Control Studies
;
Chickenpox*
;
Child*
;
Humans
;
Incidence
;
Korea*
;
Mumps
;
Republic of Korea
;
Scarlet Fever
;
Seoul*
;
Vaccination*
;
Vaccines
6.Serological Analysis and Epidemiologic Characteristics of Group A Streptococci in Seoul(1998-2000).
Sun Hee CHOI ; Yun Ho KIM ; Sung Ho CHA ; Ki Sang KIM ; Young Hee LEE
Journal of the Korean Pediatric Society 2002;45(11):1368-1372
PURPOSE: Group A streptococci have a cell wall which consists of M protein and T protein. T protein is known to be helpful in the understanding of the epidemiology of group A streptococci. To study the epidemiologic characteristics, we serotyped T protein of group A streptococci obtained from patients admitted to hospitals, or who visited OPD in five districts of Seoul the during last three years. METHODS: Group A streptococci were obtained in five districts in north, northeast, central, northwest and south Seoul from 1998 through 2000. All isolated group A streptococci were serotyped with T protein antisera(Institute of Sera and Vaccine, Prague, Czech Republic). RESULTS: In 1998, analysis of obtained total number of 92 strains revealed that T12, T4, and NT acounted for 72.2%. Among seven cases of scarlet fever, T12 was isolated in four cases and T4 was found in three cases. Two cases of tonsilar abscess produced T8 and NT. One case of cervical lymphadenitis showed T12. In 1999, 41 cases were studied showing that T12, T4, and T1 contributed 68%. Among five cases of scarlet fever, T12 and T4 make up three case. There were two cases of pneumonia(T4 and T1) and one case of cervical lymphadenitis(T8/25). In 2000, the study was performed in four districts except the central area. Among 83 isolates, T12, T4 and T1 accounted for 63.9%. There were three cases of scarlet fever(T12, T4, T5), one case of tonsillar abscess(T12), one case of pneumonia(NT) and one case of sepsis(T1). CONCLUSION: Serological analysis of T protein of group A streptococci shows no endemic specificity. The yearly pattern reveals that T12 had been decreasing but T1 had shown the opposite trend.
Abscess
;
Cell Wall
;
Epidemiology
;
Humans
;
Lymphadenitis
;
Scarlet Fever
;
Sensitivity and Specificity
;
Seoul
7.A wavelet analysis on the onset cycle of scarlet fever in Beijing and its relationship with theory of five evolutive phases and six climatic factors.
Bang-ze FU ; Qiao-ling TANG ; Ling HUANG ; Juan HE
Chinese Journal of Integrated Traditional and Western Medicine 2013;33(3):338-342
OBJECTIVETo explore the onset cycle of scarlet fever in Beijing and its association with theory of five evolutive phases and six climatic factors (FEPSCF).
METHODSBased on the monthly scarlet fever data from 1970 to 2004, Complex Morlet wavelet was adopted to analyze the annual incidence and the incidence of six climatic factors in the past 35 years. Its association with the cycles of FEP-SCF was explored. The features of heavenly stems and earthly branches in the year that the wave peak corresponded and their correlations with doctrine of FEPSCF were analyzed.
RESULTSThe annual incidence of scarlet fever and the incidence of FEPSCF had two main cycles, i.e., 5 years and 28 years. The 5-year primary cycle was consistent with 5-year cycle of FEPSCF theory. The high incidence year of 5-year primary cycle was Jinyun.
CONCLUSIONSThe cycle of five evolutive phases was consistent with the onset cycle of scarlet fever. The quasi-periodic phenomenon and multi-cycle superimposed phenomenon of FEPSCF theory existed in the incidence of scarlet fever.
China ; epidemiology ; Climate ; Humans ; Incidence ; Medicine, Chinese Traditional ; Scarlet Fever ; diagnosis ; epidemiology ; Wavelet Analysis
8.Paying attention to the epidemic of group A Streptococcus infections in multiple European and American countries.
Kai-Hu YAO ; Meng-Yang GUO ; Yun LAI ; Jiang-Hong DENG
Chinese Journal of Contemporary Pediatrics 2023;25(4):333-338
At the end of 2022, the World Health Organization reported an increase in group A Streptococcus (GAS) infections, such as scarlet fever, in multiple countries. The outbreak primarily affected children under 10 years old, and the number of deaths was higher than anticipated, causing international concern. This paper reviews the current state of the GAS disease outbreak, its causes, and response measures. The authors aim to draw attention from clinical workers in China and increase their awareness and vigilance regarding this epidemic. Healthcare workers should be aware of the potential epidemiological changes in infectious diseases that may arise after the optimization of control measures for coronavirus disease 2019 to ensure children's health.
Child
;
Humans
;
Streptococcus pyogenes
;
COVID-19/epidemiology*
;
Streptococcal Infections/epidemiology*
;
Scarlet Fever/epidemiology*
;
Epidemics
;
Disease Outbreaks
9.Spatial clustering analysis of scarlet fever incidence in China from 2016 to 2020.
Jiahao ZHANG ; Ruonan YANG ; Shuning HE ; Ping YUAN
Journal of Southern Medical University 2023;43(4):644-648
OBJECTIVE:
To investigate the incidence trend and spatial clustering characteristics of scarlet fever in China from 2016 to 2020 to provide evidence for development of regional disease prevention and control strategies.
METHODS:
The incidence data of scarlet fever in 31 provinces and municipalities in mainland China from 2016 to 2020 were obtained from the Chinese Health Statistics Yearbook and the Public Health Science Data Center led by the Chinese Center for Disease Control and Prevention.The three-dimensional spatial trend map of scarlet fever incidence in China was drawn using ArcGIS to determine the regional trend of scarlet fever incidence.GeoDa spatial autocorrelation analysis was used to explore the spatial aggregation of scarlet fever in China in recent years.
RESULTS:
From 2016 to 2020, a total of 310 816 cases of scarlet fever were reported in 31 provinces, municipalities directly under the central government and autonomous regions, with an average annual incidence of 4.48/100 000.The reported incidence decreased from 4.32/100 000 in 2016 to 1.18/100 000 in 2020(Z=103.47, P < 0.001).The incidence of scarlet fever in China showed an obvious regional clustering from 2016 to 2019(Moran's I>0, P < 0.05), but was randomly distributed in 2020(Moran's I>0, P=0.16).The incidence of scarlet fever showed a U-shaped distribution in eastern and western regions of China, and increased gradually from the southern to northern regions.Inner Mongolia Autonomous Region and Hebei and Gansu provinces had the High-high (H-H) clusters of scarlet fever in China.
CONCLUSION
Scarlet fever still has a high incidence in China with an obvious spatial clustering.For the northern regions of China with H-H clusters of scarlet fever, the allocation of health resources and public health education dynamics should be strengthened, and local scarlet fever prevention and control policies should be made to contain the hotspots of scarlet fever.
Humans
;
Incidence
;
Scarlet Fever/epidemiology*
;
China/epidemiology*
;
Spatial Analysis
;
Cluster Analysis
;
Spatio-Temporal Analysis
10.A Comparison of Clinical Characteristics between Adenoviral and Group A Streptococcal Pharyngitis in Children.
So Hyong KIM ; Hye Ryeong JEONG ; In Uk KIM ; Mu Yeol YANG ; Sung Min CHO ; Eun Kyeong KANG
Korean Journal of Pediatric Infectious Diseases 2014;21(2):121-128
PURPOSE: To compare the clinical characteristics and laboratory finding between adenoviral and group A streptococcal (GAS) pharyngitis. METHODS: A retrospective review of medical records was performed in the patients with adenovirus infection among those who were admitted for febrile respiratory disease from January 2011 to July 2013 and GAS pharyngitis among those who visited for symptoms of scarlet fever from August 2006 to July 2013. RESULTS: 179 patients (AV1 group) were diagnosed with adenoviral pharyngitis and 37 (AV2 group) of these patients had adenovirus single infection. 26 patients (GAS group) were diagnosed with scarlet fever. Adenoviral infection (AV2 group) developed in younger patients compared to GAS group (2.8+/-2.1 years vs. 5.4+/-1.8 years, P=0.000). Total durations of fever and admission were longer in AV2 (6.3+/-2.6 days vs. 3.3+/-1.9 days, P=0.000; 4.1+/-1.2 days vs. 1.9+/-1.8 days, P=0.000, respectively). WBC counts were higher in AV2 (11,449+/-5,680 cells/mm2 vs. 6,722+/-6,941 cells/mm2, P=0.000). CRP was not significantly different between AV2 and GAS group (3.8+/-3.2 mg/dL vs. 5.2+/-5.1 mg/dL, P=0.368). No difference was found between two groups in the percentage of antibiotics use (91.9% vs. 100%, P=0.261). CONCLUSION: Clinical characteristics and measures of inflammation in the laboratory findings were similar between adenoviral and GAS pharyngitis group. It is necessary to conduct the test for respiratory virus and bacteria in early stage to differentiate in the pharyngitis patients with leukocytosis and elevation of CRP level.
Adenoviridae
;
Adenoviridae Infections
;
Anti-Bacterial Agents
;
Bacteria
;
Child*
;
Fever
;
Humans
;
Inflammation
;
Leukocytosis
;
Medical Records
;
Pharyngitis*
;
Retrospective Studies
;
Scarlet Fever